Biljana Naumovic, US President, oncology, solid tumor, Johnson & Johnson Innovative Medicine, discusses the importance of ...

The transaction, finalized following regulatory clearance, includes two FDA-approved rare tumor therapies: Ogsiveo for ...

Results from the Phase III VEGA-3 trial show that a significantly higher number of patients with presbyopia who received ...

Results from the Phase III Vivacity-MG3 trial show that Imaavy provides more consistent disease control than other approved ...

Due to popularity of the medications, GLP-1s were in short supply up until recently. Obesity is a common issue among ...

Jeff Liter, CEO of Luminary, discusses his company’s approach to CAR-T therapies and why the developing Saudi market has ...

Under terms of the deal, AbbVie will acquire Capstan’s lead asset, CPTX2309—an in vivo anti-CD19 CAR T-cell therapy in Phase ...

The supplemental premarket approval application is supported by Phase III data, which showed significant improvements in neck ...

Biljana Naumovic, US President, oncology, solid tumor, Johnson & Johnson Innovative Medicine discusses key takeaways from the ...

Gamifant marks the first-ever FDA-approved treatment for both adult and pediatric patients with hemophagocytic ...

William Shatner endorsed Tinnitus Quest, a nonprofit seeking to promote new treatments and a cure for the condition. Yet, ...

Weight Watchers is Novo Nordisk's latest partnersip.